Signs of Liver Damage: Warning Symptoms, and When to See a Liver Specialist

Most liver damage causes no symptoms until it is advanced. In a 2026 Indian survey of 9,202 adults with type 2 diabetes and no liver complaints, one in four had significant liver scarring on FibroScan and one in twenty had probable cirrhosis. If you drink regularly, have diabetes or obesity, or have ever had hepatitis B or C, get tested now — do not wait for symptoms.
— Dr Chetan Kalal, DM Hepatology, Gleneagles Hospital Mumbai

A composite of a patient I meet most weeks at Gleneagles Hospital: a 48-year-old woman from Thane, diabetic for twelve years, never a drop of alcohol, who comes in because her ankles have been swelling for a month and her stomach “feels bloated”. She has no pain. She has never had jaundice. Her liver enzymes on last year’s health check were normal. Her first FibroScan reads in the cirrhosis range, and the ultrasound shows fluid in the abdomen. She has had cirrhosis, silently, for years — and her first symptom is already a sign of liver failure.

That sequence is the central problem with liver disease, and the reason I wrote this article. People search for “signs of liver damage” expecting a checklist that will tell them whether they are safe. There is no such checklist. The liver is quiet by design, the early symptoms are vague, and by the time the unmistakable signs appear the disease is usually advanced. What follows explains why, which symptoms matter and how urgently, which ones mean hospital today, and — most useful of all — who should be tested before any symptom appears.

Why does liver disease stay silent for so long?

Two facts about the organ explain it. The liver tissue itself has no pain nerves — only its outer capsule does — so a scarred liver does not hurt the way an inflamed appendix does. And it has an enormous reserve: it can lose well over half its working cells and still make enough protein, clear enough toxins and process enough bile for you to feel entirely normal. Scar tissue replaces healthy tissue over ten or twenty years, and the remaining cells keep compensating until, quite suddenly, they cannot.

Doctors use two words for this. Compensated cirrhosis means the liver is scarred but still coping — no fluid, no bleeding, no confusion. Decompensated means it has stopped coping. The 2021 Lancet seminar on cirrhosis by Ginès and colleagues puts it plainly: the disease evolves from an asymptomatic phase to a symptomatic one, whose complications bring hospitalisation and high mortality.

The numbers are sobering. In a 25-year Italian cohort of 494 people with cirrhosis followed by D’Amico and colleagues, five-year mortality was 1.5% in compensated cirrhosis without varices, 30% after a first decompensating event such as ascites or jaundice, and 88% after a second. Symptoms do not announce the beginning of liver disease. They announce its late stage. That is why I spend more clinic time persuading people with no symptoms to get tested than treating those who already have them.

Early signs of liver disease — and why they are so unreliable

I will be honest here, because much of what is written online is not. The “early symptoms” of liver disease exist, but every one is shared with a dozen commoner conditions. Persistent tiredness that sleep does not fix. Loss of appetite, or feeling full after a small meal. A dull heaviness under the right ribs. Mild nausea. Unexplained weight loss — or, in fatty liver, weight gain around the waist. Disturbed sleep. Low mood and poor concentration.

Any of these can come from thyroid trouble, anaemia, depression or simply an overworked life in Mumbai. None of them, alone, means your liver is damaged — and their absence does not mean it is healthy. The woman in the composite had none of them.

So treat these liver problem symptoms as a reason to ask your doctor for a liver check, particularly if a risk factor from the section below applies to you. Nothing more than that. The test, not the symptom, gives the answer.

What are the signs of advanced liver damage?

When the liver finally fails to compensate, the signs are specific and visible. The European guideline on decompensated cirrhosis (EASL, 2018) defines decompensation by the appearance of ascites, variceal bleeding, hepatic encephalopathy or jaundice; the Italian cohort above used the same four events.

Jaundice — yellowing of the whites of the eyes first, then the skin, with dark tea-coloured urine. In known liver disease it means the liver can no longer clear bilirubin; in someone with no known liver disease it may be hepatitis, a blocked bile duct or a drug reaction, and needs assessment within days.

Abdominal swelling (ascites) — the belly enlarges over weeks while the limbs stay thin. Fluid, not fat, and the commonest first decompensation I see. It comes from portal hypertension, the raised pressure in veins draining into a scarred liver. Ankle swelling often accompanies it, because the liver no longer makes enough albumin.

Vomiting blood or black, tarry stools — bleeding from varices, the swollen veins in the food pipe. The most dangerous sign here; see the emergency section.

Confusion, drowsiness, day-night sleep reversal — hepatic encephalopathy, from toxins such as ammonia that a failing liver no longer removes. The early form is subtle: a spouse notices the patient sleeps all day and is awake at night, repeats questions, or has had a minor car accident. Later comes a flapping tremor, then stupor.

Easy bruising and gum bleeding — the liver makes most clotting factors, and an enlarged spleen consumes platelets. Itching without a rash, worse at night, points to impaired bile flow. Spider naevi — small red spots with radiating vessels on the chest, face and arms — and palmar erythema, a blotchy redness at the base of the thumb and little finger, reflect altered hormone handling.

Muscle wasting — thinning of the temples, shoulders and thighs while the abdomen swells. Sarcopenia is among the most under-recognised signs of cirrhosis and a strong predictor of outcome. If your family says you have “lost your face”, take it seriously.

Emergency warning signs: go to a hospital now

Some signs do not wait for an outpatient appointment. If you or someone with you has any of the following, go to the nearest hospital with a gastroenterology or liver unit, today, and say the words “liver disease” at the door.

Vomiting blood, or vomit like coffee grounds. Black, sticky, foul-smelling stools. Confusion, excessive sleepiness, slurred speech or odd behaviour in someone with known liver disease — or in anyone who has recently turned yellow. Jaundice that appeared within days along with vomiting or drowsiness, which may mean acute liver failure, where hours matter and a transplant centre should be involved early. Fever, abdominal pain or rapidly worsening swelling in a person with ascites. Very little urine for a day. Fainting or a racing pulse with any of the above.

Two practical points. Give nothing to eat or drink on the way if the patient is drowsy or vomiting. And bring every medicine, supplement and herbal preparation taken in the past three months — a surprising share of the acute liver injury I see in India traces back to an ayurvedic or bodybuilding product, as I discuss in my article on drug- and herb-induced liver injury.

Who should get tested even without symptoms?

This is the section that will do the most good. Because symptoms are late, the modern approach — written into the 2024 joint European guideline on metabolic liver disease (EASL-EASD-EASO) — is to look for fibrosis actively in people who carry risk, using non-invasive tests, long before anything hurts. Run through the list. One “yes” is enough.

Alcohol. Regular drinking, most days or in heavy weekend sessions, for several years. The quantity people describe to me is almost always an underestimate. Alcohol-related liver disease remains the leading cause of cirrhosis I treat in Mumbai men.

Type 2 diabetes, obesity, or a large waist at normal weight. The DiaFib-Liver Study, published in 2026 in The Lancet Regional Health – Southeast Asia, FibroScanned 9,202 adults with type 2 diabetes across India, all free of liver symptoms. Twenty-six per cent had clinically significant fibrosis, 14% advanced fibrosis, and 5% readings consistent with cirrhosis; among those with a BMI below 25, 19% still had significant fibrosis. The authors called advanced liver disease the “fourth major complication” of diabetes. I agree: a fibrosis test is as basic as the eye and kidney checks you already have. See my fatty liver page, and the grade 2 fatty liver article on why an ultrasound grade is not enough.

Hepatitis B or C exposure. Transfusion or surgery before the mid-1990s, dialysis, tattoos or injections with reused needles, a family member with hepatitis B, or a partner with either virus. Many people carry hepatitis C for decades without a symptom, and it is now curable with tablets.

Family history of cirrhosis, liver cancer, hepatitis B, Wilson disease or haemochromatosis. Medicines and herbal products — long-term anti-tuberculosis treatment, methotrexate, anabolic steroids, or any ayurvedic, “liver tonic” or bodybuilding supplement taken for months. Results you have ignored — a raised ALT, AST or GGT on an old health check, “fatty liver” on any ultrasound, or an unexplained low platelet count.

Now the tests, which are simple and inexpensive. Liver function tests with a platelet count. Hepatitis B surface antigen and hepatitis C antibody — once in a lifetime for everyone, in my view. An abdominal ultrasound. A FIB-4 score, calculated from age, AST, ALT and platelets, which sorts people into low, indeterminate and high risk of advanced fibrosis. Anyone not clearly low-risk goes on to a FibroScan, a painless ten-minute measurement of liver stiffness. Biopsy is reserved for the few in whom results conflict.

One warning, and it is the most important sentence in this article: a normal LFT report is not a clean liver. In the Nottingham community study by Harman and colleagues, which offered FibroScan to people with hazardous drinking, diabetes or raised enzymes, 72% of those with raised liver stiffness had normal liver enzymes and would have been missed by ordinary blood testing; the programme found eleven new cases of cirrhosis, a 140% increase on what that community had diagnosed. Mofrad and colleagues showed the same on biopsy in 2003: of 51 people with fatty liver and normal ALT, 18 had bridging fibrosis or cirrhosis, and diabetes more than doubled that risk. Enzymes measure inflammation on the day. Fibrosis is what kills, and only a fibrosis test measures it.

What I tell patients who ask “am I at risk?”

If you have one of the risk factors above and have never had a FIB-4 or FibroScan, book one — this month, not next year. If the result is reassuring, repeat it every two to three years while the risk persists. If it is not, see a hepatologist rather than waiting for symptoms, because almost everything we can do for a liver — removing alcohol, curing hepatitis C, suppressing hepatitis B, reversing fatty liver, banding varices before they bleed — works far better in the compensated stage. A compensated liver can regress. A decompensated one, often, can only be replaced. I describe that stage on my cirrhosis page.

For the woman in the composite, the path is harder but not hopeless: treatment for the fluid, tight diabetes control, a nutrition plan to rebuild muscle, endoscopy for varices, six-monthly cancer surveillance, and an early conversation about transplant assessment. She will do well with that care. She would have done better with a FibroScan five years ago, and the only reason she did not have one is that nobody told her silence was not safety.

References

1. Kumar A, Panda JK, Agrawal P, et al. A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver Study. Lancet Reg Health Southeast Asia. 2026;47:100753. PMID 41938574. doi:10.1016/j.lansea.2026.100753
2. Harman DJ, Ryder SD, James MW, et al. Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography. BMJ Open. 2015;5(4):e007516. PMID 25941185. doi:10.1136/bmjopen-2014-007516
3. Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37(6):1286–1292. PMID 12774006. doi:10.1053/jhep.2003.50229
4. D’Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39(10):1180–1193. PMID 24654740. doi:10.1111/apt.12721
5. Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359–1376. PMID 34543610. doi:10.1016/S0140-6736(21)01374-X
6. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460. PMID 29653741. doi:10.1016/j.jhep.2018.03.024
7. European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines on the management of MASLD: executive summary. Diabetologia. 2024;67(11):2375–2392. PMID 38869512. doi:10.1007/s00125-024-06196-3